Wegovy has been clinically tested for safety and efficacy when following the FDA-approved dose titration
Ozempic and Wegovy both contain the active ingredient semaglutide, a GLP-1 receptor agonist that helps with weight loss via three pathways: 1) lowering the body set weight, essentially a thermostat determining when you feel full, that is believed to be located in the hypothalamus 2) delayed gastric emptying leading to a feeling of fullness 3) stimulation of insulin release from the pancreas that also leads to a feeling of satiety The only other difference between these two medications is that while Ozempic goes up to a maximum dose of 2mg, Wegovy has a maximum dose of 2.4mg
Inform PlexusDx about your plasma donation plans during your initial consultation or follow-up check-ins, as your prescriber may want to monitor your hydration status and electrolytes more closely
Self-Pay Get Healthy Medicine includes all nutrition plans, physical activity plans, behavior change plans, body composition analysis, prescriptions, and prior authorizations if needed, all for one price
Current Status of Semaglutide Litigation The legal landscape surrounding Semaglutide, particularly for the drugs Ozempic, Wegovy, and other related medications, has become notably active due to the increasing reports of serious side effects
